Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting()()()

BACKGROUND: To evaluate the efficacy and toxicities of regorafenib plus irinotecan, dose-escalated on the basis of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping, in previously heavily treated metastatic colorectal cancer (mCRC) and the prognostic values of EGFR expression, KRAS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Ma, Cheng-Jen, Huang, Ching-Wen, Chang, Tsung-Kun, Tsai, Hsiang-Lin, Su, Wei-Chih, Yeh, Yung-Sung, Chen, Po-Jung, Wang, Jaw-Yuan
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2018
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307535/
https://ncbi.nlm.nih.gov/pubmed/30594039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.12.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados